Lincoln Pharmaceuticals Ltd - 531633 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajnikant Gulabdas Patel Lincoln Pharmaceuticals Ltd - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Patel Siddharth Rajanikant Lincoln Pharmaceuticals Ltd - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajanikant Gulabdas Patel Lincoln Pharma plans to foray into regulated markets, upgrades facility
The company has upgraded its manufacturing facility at Khatraj near Ahmedabad with Rs 30-crore investment Lincoln Pharmaceuticals Ltd - 531633 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajanikant Gulabdas Patel Lincoln Pharmaceuticals Ltd - 531633 - Appointment of Company Secretary and Compliance Officer
Approved the appointment of Mr Niren Atinbhai Desai, Member of Institute of Company Secretary of India (ICSI Membership No.: A60285) as Whole Time Company Secretary & Compliance Officer of the Company w.e.f. February 28, 2020, in terms of provisions of Section 203 of the Companies Act, 2013 and Rule made thereunder and Regulation 6 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Lincoln Pharmaceuticals Ltd - 531633 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Approved the resignation tendered by Mr. Bhavik Paresh Parikh, Company Secretary & Compliance Officer of the Company from the position of Company Secretary & Compliance Officer of the Company to be made effective from February 27, 2020 after the closure of the business hours. Lincoln Pharmaceuticals Ltd - 531633 - Record Date For Interim Dividend
1. Approved and declared the payment of Interim Dividend of Rs. 1.50 (One Rupee and Fifty Paisa only) Per Share of Face Value of Rs. 10/- Each for the Financial Year 2019-2020. (i.e. 15% Per Share). 2. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Friday, March 06, 2020 is fixed as Record Date for determining entitlement of Equity Shareholders to receive Interim Dividend. Lincoln Pharmaceuticals Ltd - 531633 - Corporate Action-Board approves Dividend
Further to our Intimation dated February 24, 2020, Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we have to inform you that the meeting of Board of Directors of the Company held today, i.e. February 27, 2020, inter-alia consider the following: 1. Approved and declared the payment of Interim Dividend of Rs. 1.50 (One Rupee and Fifty Paisa only) Per Share of Face Value of Rs. 10/- Each for the Financial Year 2019-2020. (i.e. 15% Per Share). 2. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Friday, March 06, 2020 is fixed as Record Date for determining entitlement of Equity Shareholders to receive Interim Dividend. Lincoln Pharmaceuticals Ltd - 531633 - Outcome Of Board Meeting
we have to inform you that the meeting of Board of Directors of the Company held today, i.e. February 27, 2020, inter-alia consider : 1. Approved and declared the payment of Interim Dividend of Rs. 1.50 (One Rupee and Fifty Paisa only) Per Share of Face Value of Rs. 10/- Each for the Financial Year 2019-2020. (i.e. 15% Per Share). 2. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Friday, March 06, 2020 is fixed as Record Date for determining entitlement of Equity Shareholders to receive Interim Dividend. 3. Approved the resignation tendered by Mr. Bhavik Paresh Parikh, from the position of Company Secretary & Compliance Officer w.e.f from February 27, 2020 after the closure of the business hours. 4. Approved the appointment of Mr Niren Atinbhai Desai, Member of Institute of Company Secretary of India (ICSI Membership No.: A60285) as Whole Time Company Secretary & Compliance Officer of the Company w.e.f. February 28, 2020,